Joint Venture13 Feb 2026, 01:59 pm
Alkem Laboratories Incorporates Joint Venture in Saudi Arabia with Vitals Biotech Company
AI Summary
Alkem Laboratories Ltd has updated an earlier intimation regarding the execution of a Shareholders’ Agreement for the incorporation of a Joint Venture (JV) in the Kingdom of Saudi Arabia. The JV will be formed with Mr. Abdulaziz Alsheikh, a Saudi Arabian national, who will hold 49% of the total share capital. The remaining 51% will be held by Alkem Laboratories Ltd. The Board of Directors has approved an amendment to the Shareholders’ Agreement, replacing the JV Partner with Vitals Biotech Company, a wholly owned company of the JV Partner. This decision was made at the Board meeting held on 13th February, 2026.
Key Highlights
- Alkem Laboratories Ltd is incorporating a Joint Venture in Saudi Arabia.
- The JV will be formed with Mr. Abdulaziz Alsheikh, who will hold 49% of the total share capital.
- Alkem Laboratories Ltd will hold 51% of the total share capital.
- The Board of Directors has approved an amendment to the Shareholders’ Agreement, replacing the JV Partner with Vitals Biotech Company.
- Vitals Biotech Company is a wholly owned company of the JV Partner.